Publications

Scientific excellence is not an end in itself, but is a crucial tool for efficient translation of new ideas into viable solutions.

PublicationsPublicationsPublicationsPublications

2010

Kettner C, Field D, Sansone S, Taylor C, Aerts J, Binns N, Blake A, Britten CM, Marco A de, Fostel J, Gaudet P, González-Beltrán A, Hardy N, Hellemans J, Hermjakob H, Juty N, Leebens-Mack J, Maguire E, Neumann S, Orchard S, Parkinson H, Piel W, Ranganathan S, Rocca-Serra P, Santarsiero A, Shotton D, Sterk P, Untergasser A, Whetzel PL. (2010)

Meeting Report from the Second “Minimum Information for Biological and Biomedical Investigations” (MIBBI) workshop.

Stand. Genomic Sci. 2010, 3:259-266.

Icon Plus

Tang ST, van Meijgaarden, Krista E, Caccamo N, Guggino G, Klein MR, van Weeren P, Kazi F, Stryhn A, Zaigler A, Sahin U, Buus S, Dieli F, Lund O, Ottenhoff, Tom H M. (2010)

Genome-based in silico identification of new Mycobacterium tuberculosis antigens activating polyfunctional CD8+ T cells in human tuberculosis.

Journal of immunology (Baltimore, Md.: 1950) 2011, 186:1068-1080.

Icon Plus

Singh SK, Laske K, Gouttefangeas C, Britten CM, Welters, Marij J P. (2010)

CIMT 2010: report on the eighth annual meeting of the Association for Cancer Immunotherapy, May 26-28, 2010, Mainz, Germany.

Cancer immunology, immunotherapy: CII 2011, 60:443-450.

Icon Plus

Britten CM, Janetzki S, van der Burg, S H, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief, C J M, O’Donnell-Tormey J, Odunsi K, Old LJ, Pawelec G, Roep BO, Romero P, Hoos A, Davis MM. (2010)

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond.

Cancer immunology, immunotherapy: CII 2011, 60:15-22.

Icon Plus

Koslowski, M., Luxemburger, U., Türeci, Ö., and Sahin, U. (2010)

Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1alpha.

Oncogene. 2011 Feb 17;30(7):876-82.

Icon Plus

Gorr, T.A., Wichmann, D., Pilarsky, C., Theurillat, J.P., Fabrizius, A., Laufs, T., Bauer, T., Koslowski, M., Horn, S., and Burmester, T., et al. (2010)

Old proteins – new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.

Acta Physiol (Oxf). 2011 Jul;202(3):563-81

Icon Plus

Kreiter S, Selmi A, Diken M, Koslowski M, Britten CM, Huber C, Türeci O, Sahin U:. (2010)

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

Cancer research 2010, 70:9031-9040.

Icon Plus

Castle JC, Armour CD, Löwer M, Haynor D, Biery M, Bouzek H, Chen R, Jackson S, Johnson JM, Rohl CA, Raymond CK. (2010)

Digital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification.

PloS one 2010, 5:e11779.

Icon Plus

Bland, C.S., Wang, E.T., Vu, A., David, M.P., Castle, J.C., Johnson, J.M., Burge, C.B., and Cooper, T.A. (2010)

Global regulation of alternative splicing during myogenic differentiation.

Nucleic Acids Res. 2010 Nov;38(21):7651-64.

Icon Plus

Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, Löwer M, Welters, M J P, Ottensmeier C, van der Burg, S H, Britten CM. (2010)

Response definition criteria for ELISPOT assays revisited.

Cancer immunology, immunotherapy: CII 2010, 59:1489-1501.

Icon Plus

Castle JC, Biery M, Bouzek H, Xie T, Chen R, Misura K, Jackson S, Armour CD, Johnson JM, Rohl CA, Raymond CK. (2010)

DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing.

BMC genomics 2010, 11:244.

Icon Plus

Mander A, Gouttefangeas C, Ottensmeier C, Welters, M J P, Low L, van der Burg, S H, Britten CM. (2010)

Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.

Cancer immunology, immunotherapy: CII 2010, 59:619-627.

Icon Plus

Janetzki S, Price L, Britten CM, van der Burg, S. H., Caterini J, Currier JR, Ferrari G, Gouttefangeas C, Hayes P, Kaempgen E, Lennerz V, Nihlmark K, Souza V, Hoos A. (2010)

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells.

Cancer Immunol Immunother 2010, 59:609-618.

Icon Plus
Back to Top Icon